Steven Yatomi Clarke – CEO and Managing Director – Prescient Therapeutics (ASX:PTX) is a clinical-stage biotech company developing personalised medicine approaches to cancer, including targeted and cellular therapies.
Copyright 2023 – Finance News Network
Source: Finance News Network
06 Sep 2024 - Bernie Fernandes, State Manager (WA & SA) of Sequoia Financial Group (ASX:SEQ), talks with CEO and Managing Director Garry Crole. Bernie shares insights for advisors from his long career.
Read More27 Oct 2022 - icetana Limited (ASX:ICE) CEO and Managing Director Matt Macfarlane discusses the company's recent deal with Japanese group Macnica and the launch of a new product.
Read More17 Jan 2022 - eCargo Holdings Limited (ASX:ECG) Head of Corporate Marketing Lewis Bacon provides an insight into how eCommerce will continue to grow in China and across Asia, and eCargo’s position to assist brands with market entry.
Read More11 Dec 2020 - Novatti Group Limited (ASX:NOV) Managing Director Peter Cook discusses the company's strategy of partnering with Tier 1 companies, including Ripple, Google Pay and Samsung Pay.
Read More28 Aug 2024 - Focused on supplying high-purity manganese for electric vehicles, Euro Manganese Limited (ASX:EMN) is advancing a project in the Czech Republic that repurposes historical mine tailings. The company's recent offtake agreement with Wildcat Discovery Technologies is a significant milestone, with more agreements and funding efforts planned for the near future.
Read More28 Sep 2020 - Respiri Limited (ASX:RSH) CEO Marjan Mikel discusses clinical results from the company's innovative asthma management tool wheezo, a combination eHealth app and handheld device, as well as the company's strategy and outlook.
Read More30 Jul 2021 - Novatti Group Limited (ASX:NOV) CEO, Peter Cook, provides an update on activities from the company's June quarter, discussing growth in platforms and infrastructure and the recent capital raise.
Read More30 Oct 2023 - Amanda Harsas, Finance Director of Atlantic Lithium (ASX:A11), discusses the company's flagship Ewoyaa Project in Ghana, its strategic partnerships, Ghanaian government support, and prospects for resource upgrades, providing insights into the burgeoning lithium industry in the region.
Read More11 Jun 2020 - MGM Wireless Limited (ASX:MWR) CEO, Mark Fortunatow talks about growth in the company's SPACETALK brand of wearables for kids, new product categories, distribution, and growth in wearables from niche product to mainstream.
Read More26 Aug 2021 - Chimeric Therapeutics Limited (ASX:CHM) Chief Operating Officer Jennifer Chow talks about the company's licensing of a novel, third-generation CDH17 CAR T cell therapy from the University of Pennsylvania, its recent FDA IND clearance and plans for ongoing growth.
Read More
